Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Nephron
|
July 8, 2026
ANY ROLE FOR RENAL-DERIVED EXTRACELLULAR VESICLES MANIPULATION FOR CARDIOPROTECTION IN CKD?
Aneliya Parvanova, Piero Ruggenenti
Clinical Kidney Journal
|
March 25, 2025
Mechanisms and treatment of obesity-related hypertension-Part 2: Treatments
Aneliya Parvanova, Manuela Abbate, Elia Reseghetti, et al.
Clinical Kidney Journal
|
January 8, 2024
Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms
Aneliya Parvanova, Elia Reseghetti, Manuela Abbate, et al.
Expert Opinion on Pharmacotherapy
|
September 8, 2005
Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade
Aneliya Parvanova, Carlos Chiurchiu, Piero Ruggenenti, et al.
Diabetes Care
|
November 28, 2002
Hyperhomocysteinemia and increased risk of retinopathy: a cross-sectional, case-control study in patients with type 2 diabetes
Aneliya Parvanova, Ilian Iliev, Borislav D Dimitrov, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2004
Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes
Aneliya Parvanova, Ilian Iliev, Marco Filipponi, et al.
Diabetes Care
|
April 30, 2008
Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
Piero Ruggenenti, Ilian Iliev, Grazia Maria Costa, et al.
Diabetes/Metabolism Research and Reviews
|
May 17, 2024
MAFLD and glomerular hyperfiltration in subjects with normoglycemia, prediabetes and type 2 diabetes: A cross-sectional population study
Manuela Abbate, Aneliya Parvanova, Ángel Arturo López-González, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial
Aneliya Parvanova, Irene M van der Meer, Ilian Iliev, et al.
Acta Diabetologica
|
October 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial
Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Nephron
|
July 8, 2026
ANY ROLE FOR RENAL-DERIVED EXTRACELLULAR VESICLES MANIPULATION FOR CARDIOPROTECTION IN CKD?
Aneliya Parvanova, Piero Ruggenenti
Clinical Kidney Journal
|
March 25, 2025
Mechanisms and treatment of obesity-related hypertension-Part 2: Treatments
Aneliya Parvanova, Manuela Abbate, Elia Reseghetti, et al.
Clinical Kidney Journal
|
January 8, 2024
Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms
Aneliya Parvanova, Elia Reseghetti, Manuela Abbate, et al.
Expert Opinion on Pharmacotherapy
|
September 8, 2005
Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade
Aneliya Parvanova, Carlos Chiurchiu, Piero Ruggenenti, et al.
Diabetes Care
|
November 28, 2002
Hyperhomocysteinemia and increased risk of retinopathy: a cross-sectional, case-control study in patients with type 2 diabetes
Aneliya Parvanova, Ilian Iliev, Borislav D Dimitrov, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 10, 2004
Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes
Aneliya Parvanova, Ilian Iliev, Marco Filipponi, et al.
Diabetes Care
|
April 30, 2008
Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
Piero Ruggenenti, Ilian Iliev, Grazia Maria Costa, et al.
Diabetes/Metabolism Research and Reviews
|
May 17, 2024
MAFLD and glomerular hyperfiltration in subjects with normoglycemia, prediabetes and type 2 diabetes: A cross-sectional population study
Manuela Abbate, Aneliya Parvanova, Ángel Arturo López-González, et al.
The Lancet. Diabetes & Endocrinology
|
March 14, 2014
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial
Aneliya Parvanova, Irene M van der Meer, Ilian Iliev, et al.
Acta Diabetologica
|
October 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial
Fabiola Carrara, Piero Ruggenenti, Annalisa Perna, et al.
Page
of 3